Evidence map›Paper›PMID 41459972›Full record

ArticleMicrobiology spectrum2026

Molecular epidemiology of drug resistance and transmission of

Yang Deng, Xin He, Cise Bibu, Yi-Xuan Ren, Yong Fang, Labu Qubi, Ai-Zhen He, Wulang Acheng, Chuan-You Li, Jie Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yang DengBeijing Center for Disease Prevention and Control, Beijing, China.ORCID 0009-0009-2727-0960
Xin HeMeigu County Disease Prevention and Control Center, Sichuan, China.
Cise BibuMeigu County Disease Prevention and Control Center, Sichuan, China.
Yi-Xuan RenBeijing Center for Disease Prevention and Control, Beijing, China.
Yong FangMeigu County Disease Prevention and Control Center, Sichuan, China.
Labu QubiMeigu County Disease Prevention and Control Center, Sichuan, China.
Ai-Zhen HeMeigu County Disease Prevention and Control Center, Sichuan, China.
Wulang AchengMeigu County Disease Prevention and Control Center, Sichuan, China.
Chuan-You LiBeijing Center for Disease Prevention and Control, Beijing, China.
Jie ZhangBeijing Center for Disease Prevention and Control, Beijing, China.ORCID 0000-0002-4780-8889
Jie LiBeijing Center for Disease Prevention and Control, Beijing, China.ORCID 0000-0003-3010-249X

Funding

Open project of small-fund for capactiy buliding in Liangshan supported by CASAPC LS20240R 04
6 · The paper itself

Abstract

Tuberculosis (TB) remains a major public health challenge in China. Meigu County, in Liangshan Yi Autonomous Prefecture, Sichuan Province, is severely affected by a high TB burden, a situation exacerbated by its geographic isolation and socioeconomic constraints. This study used DNA microarray technology to assess drug resistance in 378 IMPORTANCE: This study provided a critically important investigation into the molecular epidemiology of drug-resistant tuberculosis in Meigu County, a remote and high-burden region in Sichuan Province, China. By combining DNA microarray chip technology and whole-genome sequencing, the researchers characterized the genetic makeup, drug resistance patterns, and transmission dynamics of strains of

Indexed as

Antitubercular AgentsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultAgedBacterial ProteinsChildChinaDrug Resistance, Multiple, BacterialFemaleHumansIsoniazidMaleMicrobial Sensitivity TestsMiddle AgedAntitubercular AgentsBacterial ProteinsIsoniazidRifampindrug resistanceMeigu Countymolecular epidemiologyMycobacterium tuberculosistransmission clusterswhole-genome sequencing

Identifiers

PMID41459972
PMCPMC12889122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.